যুক্তরাজ্য - ইংরেজি - myHealthbox

rosemont pharmaceuticals ltd - amlodipine - oral solution - 1mg/ml - calcium channel blockers, selective calcium channel blockers with mainly vascular effects - hypertension; chronic stable angina pectoris; vasospastic (prinzmetal's) angina

যুক্তরাজ্য - ইংরেজি - myHealthbox

rosemont pharmaceuticals ltd - risperidone - oral solution - 1mg/ml - other antipsychotics - it is indicated for the treatment of schizophrenia; for the treatment of moderate to severe manic episodes associated with bipolar disorders; for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer's dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others.; for the short-term symptomatic treatment (up to 6 weeks) of persistent aggression in conduct disorder in children from the age of 5 years and adolescents with subaverage intellectual functioning or mental retardation diagnosed according to dsm-iv criteria, in whom the severity of aggressive or other disruptive behaviours require pharmacologic treatment.

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspar pharmaceuticals ltd - aspirin - oral tablet - 300mg

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

ferndale pharmaceuticals ltd - lidocaine - cutaneous cream - 40mg/1gram

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

colorama pharmaceuticals ltd - lidocaine - cutaneous cream - 40mg/1gram

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

idorsia pharmaceuticals ltd - daridorexant (unii: lmq24g57e9) (daridorexant - unii:lmq24g57e9) - quviviq is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance [see clinical studies (14.1)] . quviviq is contraindicated: - in patients with narcolepsy. - in patients with a history of hypersensitivity to daridorexant or any components of quviviq. angioedema with pharyngeal involvement has been reported [see adverse reactions (6.2)] . pregnancy exposure registry there will be a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to quviviq during pregnancy. pregnant women exposed to quviviq and healthcare providers are encouraged to call idorsia pharmaceuticals ltd at 1-833-400-9611. risk summary there are no available data on quviviq use in pregnant women to evaluate for drug-associated risks of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. in animal reproduction studies, oral administration of daridorexant to pregnant rats and rabbits during the period of organogenesi

ইস্রায়েল - ইংরেজি - Ministry of Health

padagis israel pharmaceuticals ltd, israel - mebeverine hydrochloride - tablets - mebeverine hydrochloride 135 mg - mebeverine - mebeverine - irritable bowel syndrome and conditions included in this group such as: chronic irritable colon, gastro- intestinal spasm secondary to organic diseases

ইস্রায়েল - ইংরেজি - Ministry of Health

padagis israel pharmaceuticals ltd, israel - lactulose - syrup - lactulose 66.7 g / 100 ml - lactulose - lactulose - constipation. acute and chronic hepatic encephalopathy.

ইস্রায়েল - ইংরেজি - Ministry of Health

padagis israel pharmaceuticals ltd, israel - clotrimazole - solution - clotrimazole 1 % - clotrimazole - clotrimazole - skin infection caused by dermatophytes or candida species.

ইস্রায়েল - ইংরেজি - Ministry of Health

padagis israel pharmaceuticals ltd, israel - clotrimazole - cream - clotrimazole 1 %w/w - clotrimazole - clotrimazole - for the treatment of fungal infections of the skin and mucosa caused by dermatophytes, yeasts, molds and other fungi such as malassezia furfur, as well as skin infections caused by corynebacterium minutissimum.indicated also for candida vulvitis and candida balanitis.